HealthQuill Dizziness
Akebia Therapeutics, a US Massachusetts-based biotechnology company, has got the regulatorā€™s approval for its Vafseo drug to treatĀ anaemia in patients undergoing dialysis for at least three months.
Drugs Health Pharma

FDA clears Akebiaā€™s drug to treat anaemia in acute kidney disease

HQ Team March 28, 2024: Akebia Therapeutics, a US Massachusetts-based biotechnology company, has got the regulatorā€™s approval for its Vafseo drug to treatĀ anaemia.

Read More
Covid-19 drug from repurposed liver disease medicine
Drugs Health Medical

New Study gives insights into long COVID symptoms and treatment implications

Some people continue to suffer from the underlying effects of COVID-19, which manifests in the form of poor health. People suffer from anxiety.

Read More
Merck announced its experimental trial on patients with pulmonary arterial hypertension had led to an extension in walking distance and reduced exacerbating the condition by 84%.
Drugs Medical Pharma

Merck says trial hypertension drug enhances patientsā€™ walk timeļæ¼

Merck announced its experimental trial on patients with pulmonary arterial hypertension had led to an extension in walking distance and reduced exacerbating the.

Read More